| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/11/2006 | US7026313 2-thia-1,6,8-triaza-naphthalene-2,2-dioxides are kinase inhibitors |
| 04/11/2006 | US7026312 Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| 04/11/2006 | US7026311 Dibenzodiazepine derivatives, their preparation and use |
| 04/11/2006 | US7026310 Heteroaryl derivatives and their use as medicaments |
| 04/11/2006 | US7026309 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 04/11/2006 | US7026307 Decyclization of a 1-heterocyclylmethyl-2-nitroimino-1,3,5-hexahydrotriazine compound with hydrogen halide in presence of a nitrile to form a 1-heterocyclylmethyl-2-nitroguanidine compound |
| 04/11/2006 | US7026306 Steroidal quinols and their use for antioxidant therapy |
| 04/11/2006 | US7026305 Anti-HIV agents with dual sites of action |
| 04/11/2006 | US7026304 especially for blocking rocuronium, vecuronium, pancuronium and rapacuronium salts; kits. |
| 04/11/2006 | US7026303 xylose or arabinose surrounded by a hydrophobic layer and/or a hydrophilic layer, used for normalizing bowel function, inducing laxation, providing dietary fiber, and/or reducing serum cholesterol levels |
| 04/11/2006 | US7026302 Compositions and methods for treating mammals with modified alginates and modified pectins |
| 04/11/2006 | US7026301 Method of orally treating inflammatory skin conditions with prodrugs of 5-fluorouracil |
| 04/11/2006 | US7026298 Diarrhea therapy; gel mouth rehydration solution |
| 04/11/2006 | US7026297 Neuroprotective agents |
| 04/11/2006 | US7026296 Prevent cytokine biosynthesis; topical applying to eye |
| 04/11/2006 | US7026295 Administering a lactoferrin formulation to provide therapy for cardiovascular disease |
| 04/11/2006 | US7026292 improving the tissue inductive activity of BMPs, especially in a jaw bone for use in periodontal or dental reconstructive procedures; inducing local tissue formation from a progenitor cell using prosthetic devices coated with the factor |
| 04/11/2006 | US7026289 Method and compositions for treating hyperlipidemia and other conditions |
| 04/11/2006 | US7026288 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 04/11/2006 | US7026285 Immunomodulating polymers |
| 04/11/2006 | US7026284 Formative agent of protein complex |
| 04/11/2006 | US7026270 malayamycin A and desmethylmalayamycin A prepared from a previously unknown strain of Streptomyces malaysiensis, used for combating or controlling phytopathogenic fungi |
| 04/11/2006 | US7026160 Oral bacteriotherapy compositions and methods |
| 04/11/2006 | US7026156 nucleic acid molecules that encode antigenic or membrane-targeting portions of i-antigen proteins, DNA and protein subunit vaccines; transformed Tetrahymena host cell |
| 04/11/2006 | US7026155 Reducing microorganismal propagation; obtain bacteria, methylate nucleotide sequences, incubate with bactericide, monitor propagation microoganisms |
| 04/11/2006 | US7026136 compounds that inhibit activity of the AcrAB or AcrAB-like efflux pump are identified as compounds which reduce antibiotic resistance in a microbe that has 2 chromosomal mutations in a gene encoding an antibiotic target that renders it resistant and increased expression of at least one efflux pump |
| 04/11/2006 | US7026130 screening chemical compounds for ability to compete with hepatitis C virus for binding to a HCV receptor by comparing the binding of the HCV receptor to the E2 protein of HCV in the presence of said compound to the binding of the receptor to the protein in the absence of the compound |
| 04/11/2006 | US7025998 Phytoestrogens and probiotic for women's health |
| 04/11/2006 | US7025993 Herbal composition PHY906 and its use in chemotherapy |
| 04/11/2006 | US7025990 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 04/11/2006 | US7025989 At least three delayed release dosages forms, each of which has a different release profile, with the Cmax for the antibiotic product being reached in less than about twelve hours. |
| 04/11/2006 | US7025988 Forming dehydration-rehydration vesicles with lipophilic drug paclitaxel, dissolving sugar into the aqueous suspension; drug delivery of antitumor treatment |
| 04/11/2006 | US7025987 Delivery system for nucleic acids |
| 04/11/2006 | US7025985 Dihydroxyphenyl compounds and glucoside compounds thereof |
| 04/11/2006 | US7025984 Controlling appetite; using ethyl oleate |
| 04/11/2006 | US7025983 Water soluble film forming polymer |
| 04/11/2006 | US7025979 Male contraceptive formulation comprising norethisterone |
| 04/11/2006 | US7025978 Use of polysiloxanes containing quarternary amino groups as formulation auxiliary agents, and agents containing the same |
| 04/11/2006 | US7025977 Mixture of hydroquinone and ascorbic compound |
| 04/11/2006 | US7025975 Galenical formulations |
| 04/11/2006 | US7025971 By interacting with periplasmic molecular chaperones so the assemlbly of pili is prevented or inhibited and thereby the infectivity of the bacteria is diminished; used in drug design |
| 04/11/2006 | US7025966 Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin |
| 04/11/2006 | US7025958 Eyes, ears, nose, throat; ethylene oxide-propylene oxide copolymer microbiocide |
| 04/11/2006 | US7025957 Topically applied to darkened skin areas |
| 04/11/2006 | CA2411008C Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 04/11/2006 | CA2372710C Laminates containing an active substance for transdermal systems |
| 04/11/2006 | CA2335582C Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 04/11/2006 | CA2329922C Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 04/11/2006 | CA2322558C Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| 04/11/2006 | CA2317549C Composition for enhancing transport through lipid-containing membranes, and uses thereof |
| 04/11/2006 | CA2282840C S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 04/11/2006 | CA2281702C (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 04/11/2006 | CA2274530C Process for producing 5-arylthio imidazole derivatives |
| 04/11/2006 | CA2245758C Benzo[c]quinolizine derivatives, their preparation and use as 5.alpha.-reductases inhibitors |
| 04/11/2006 | CA2244897C 4-anilinoquinazoline derivatives |
| 04/11/2006 | CA2233842C Novel heterocyclic derivatives having indoline, indole or tetrahydroquinoline ring and pharmaceutical use thereof |
| 04/11/2006 | CA2217030C Protease inhibiting succinic acid derivatives |
| 04/11/2006 | CA2199117C Compounds and methods for the treatment of cancer |
| 04/11/2006 | CA2198383C Benzene compound and pharmaceutical use thereof |
| 04/11/2006 | CA2195759C Tetrahydropyridinylmethyl derivatives of pyrrolo[2,3-b]pyridine |
| 04/11/2006 | CA2187030C Improved anti-dandruff shampoo |
| 04/11/2006 | CA2181570C Metalloproteinase inhibitors |
| 04/11/2006 | CA2178632C Pharmaceutical compositions containing hiv protease inhibitors |
| 04/11/2006 | CA2157128C Camptothecin derivatives, preparations thereof and antitumor agents |
| 04/11/2006 | CA2155013C C2 taxane derivatives and pharmaceutical compositions containing them |
| 04/11/2006 | CA2089440C Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicaments containing them |
| 04/11/2006 | CA2089439C 3,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 04/08/2006 | CA2485449A1 Method for preventing mucositis during cancer therapy |
| 04/06/2006 | WO2008034796A2 Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors |
| 04/06/2006 | WO2006037117A1 Substituted heterocyclic compounds and methods of use |
| 04/06/2006 | WO2006037116A2 Semi-solid delivery vehicle and pharmaceutical compositions |
| 04/06/2006 | WO2006037106A2 Carboxy-amido-triazoles for the localized treatment of ocular diseases |
| 04/06/2006 | WO2006037105A2 Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof |
| 04/06/2006 | WO2006037089A2 Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| 04/06/2006 | WO2006037061A2 Compositions and methods of using d-dopa to treat parkinson's disease |
| 04/06/2006 | WO2006037050A2 Methods for treating congestive heart failure |
| 04/06/2006 | WO2006037047A2 The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents |
| 04/06/2006 | WO2006037043A1 Synthesis of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 04/06/2006 | WO2006037032A2 Prodrugs of protein tyrosine kinase inhibitors |
| 04/06/2006 | WO2006037031A2 Formulations and methods for treatment of inflammatory diseases |
| 04/06/2006 | WO2006037029A2 Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 04/06/2006 | WO2006037028A2 Methods and compositions for treating flaviviruses, pestiviruses and hepacivirus |
| 04/06/2006 | WO2006037024A2 Salts of decitabine |
| 04/06/2006 | WO2006037023A2 Use of inhibitors of 24-hydroxylase in the treatment of cancer |
| 04/06/2006 | WO2006037016A2 Novel therapy for treatment of chronic degenerative brain diseases and nervous system injury |
| 04/06/2006 | WO2006036994A2 Modulators of crth2, cox-2 and faah |
| 04/06/2006 | WO2006036981A2 Small molecule modulators of cytokine activity |
| 04/06/2006 | WO2006036956A2 Therapeutic regimen for treating cancer using quassinoids and other chemotherapeutic agents |
| 04/06/2006 | WO2006036941A2 Specific kinase inhibitors |
| 04/06/2006 | WO2006036936A2 The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents |
| 04/06/2006 | WO2006036932A2 Sulfonamides and uses thereof |
| 04/06/2006 | WO2006036928A2 Inhibitors of matrix metalloproteinases to treat neurological disorders |
| 04/06/2006 | WO2006036927A1 Crytalline forms of a pyrazolo `3, 4-c ! pyridine factor xa inhibitor |
| 04/06/2006 | WO2006036892A2 Use of inhibitors of 24-hydroxylase in the treatment of cancer |
| 04/06/2006 | WO2006036883A2 Imidazo{4,5-b}pyrazinone inhibitors of protein kinases |
| 04/06/2006 | WO2006036874A1 Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| 04/06/2006 | WO2006036816A2 Chemical compounds |
| 04/06/2006 | WO2006036743A2 Halocombstatins and methods of synthesis thereof |
| 04/06/2006 | WO2006036686A2 Method of treating organophosphorous poisoning |
| 04/06/2006 | WO2006036681A2 Cartilage filling device |